[HTML][HTML] COVID-19 and indirect liver injury: a narrative synthesis of the evidence

F Idalsoaga, G Ayares, JP Arab… - Journal of Clinical and …, 2021 - ncbi.nlm.nih.gov
The liver is frequently affected by severe acute respiratory syndrome-coronavirus 2 (SARS-
CoV-2) infection. The most common manifestations are mildly elevated alanine …

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence

M Buchynskyi, I Kamyshna, V Oksenych, N Zavidniuk… - Viruses, 2023 - mdpi.com
The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …

Cellular and humoral immune response after mRNA‐1273 SARS‐CoV‐2 vaccine in liver and heart transplant recipients

S Herrera, J Colmenero, M Pascal… - American Journal of …, 2021 - Wiley Online Library
Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

Renal involvement in COVID-19: Focus on kidney transplant sector

C Sagnelli, A Sica, M Gallo, G Peluso, F Varlese… - Infection, 2021 - Springer
Introduction Kidney transplant recipients and patients on the waiting list for kidney transplant
who acquire SARS-CoV-2 infection are at serious risk of developing severe COVID-19, with …

[HTML][HTML] Nephrotic syndrome in adult patients with COVID-19 infection or post COVID-19 vaccine: a systematic review

I Cancarevic, M Nassar, L Medina, A Sanchez, A Parikh… - Cureus, 2022 - ncbi.nlm.nih.gov
Nephrotic syndrome is a condition characterized by damage to podocytes that results in
significant proteinuria, edema, hyperlipidemia, and hypercoagulability. Infections and …

Follow‐up of renal transplant recipients after acute COVID‐19—A prospective cohort single‐center study

N Basic‐Jukic, I Juric, V Furic‐Cunko… - Immunity …, 2021 - Wiley Online Library
Introduction Although most patients recover within several weeks after acute COVID‐19,
some of them develop long‐lasting clinical symptoms. Renal transplant recipients have an …

[HTML][HTML] Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

L Peter, DJ Wendering, S Schlickeiser… - … Therapy-Methods & …, 2022 - cell.com
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …

COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study

M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific Reports, 2022 - nature.com
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …

Tacrolimus toxicity due to enzyme inhibition from ritonavir

I Snee, J Drobina, M Mazer-Amirshahi - The American Journal of …, 2023 - Elsevier
Tacrolimus is commonly used for immunosuppression in patients following solid organ
transplantation. For transplant patients with COVID-19 infection, early treatment is indicated …

Hospitalization and death after recovery from acute COVID‐19 among renal transplant recipients

N Basic‐Jukic, S Racki, I Tolj, M Aleckovic… - Clinical …, 2022 - Wiley Online Library
Introduction Data on post‐COVID‐19 in renal transplant recipients (RTR) is scarce. We
investigated the rate of hospitalizations, reasons for hospital admission, and mortality rate …